Patent details

EP2661266 Title: CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES

Basic Information

Publication number:
EP2661266
PCT Application Number:
US2012020548
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP127324085
PCT Publication Number:
WO2012094636
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES
French Title of Invention:
TRAITEMENTS À BASE DE LIGAND DE RÉCEPTEUR CHIMIOSENSORIEL
German Title of Invention:
AUF CHEMOSENSORISCHEN REZEPTORLIGANDEN BASIERENDE THERAPIEN
SPC Number:

Dates

Filing date:
06/01/2012
Grant date:
16/09/2020
EP Publication Date:
13/11/2013
PCT Publication Date:
12/07/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/09/2020
EP B1 Publication Date:
16/09/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
06/01/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/09/2020
 
 

Name:
Anji Pharma (US) LLC
Address:
4 Dana Road, Boxford, MA 01921, United States (US)

Agent

Name:
Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
From:
04/11/2020
Address:
Zweibrückenstrasse 5-7, 80331, München, Germany (DE)
To:

Inventor

1

Name:
BEELEY, Nigel R. A.
Address:
United States (US)

2

Name:
JONES, Christopher R. G.
Address:
United States (US)

3

Name:
FINEMAN, Mark S.
Address:
United States (US)

4

Name:
BROWN, Martin R.
Address:
United States (US)

5

Name:
BARON, Alain D.
Address:
United States (US)

Priority

Priority Number:
201161430914 P
Priority Date:
07/01/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/155; A61K 31/194; A61K 31/198; A61K 31/201; A61K 31/353; A61K 31/4709; A61K 31/575; A61K 31/7016; A61K 31/7032; A61K 31/704; A61P 1/00; A61P 3/00; A61P 3/04; A61P 3/10; A61P 7/12; A61P 19/10; A61P 21/00; A61P 25/24; A61P 37/00;

Publication

European Patent Bulletin

1

Issue number:
202038
Publication date:
16/09/2020
Description:
Grant (B1)

2

Issue number:
202039
Publication date:
23/09/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
02/02/2026
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
30/12/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
04/11/2020 Outgoing Correspondence 1
04/11/2020 Power Of Attorney 2